Amgen Inc. buy Wells Fargo & Company
Start price
13.03.23
/
50%
€219.90
Target price
13.03.24
€247.40
Performance (%)
14.78%
End price
14.03.24
€252.40
Summary
This prediction ended on 14.03.24 with a price of €252.40. The BUY prediction by Wells_Fargo___Compan finished with a performance of 14.78%. Dividends of €7.97 are taken into consideration when calculating the performance. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | -0.795% | -0.795% | 18.723% | 29.905% |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% | 49.144% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% | 82.047% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% | 60.623% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% | 59.657% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $265.00 price target on the stock, down previously from $275.00.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten